Invesco Mutual Fund launches Invesco India Pharma and Healthcare Fund

18 Aug,   2026 By: Eastern Fin Research Team #Mutual Fund

NFO period: 18th Aug - 01st Sep, 2026

Highlights of the NFO:

  • Scheme type - An open ended equity scheme investing in Pharma, Healthcare and allied sectors

  • Investment objective - To generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

  • Product suitability - This product is suitable for investors who are seeking to generate capital appreciation over long term. Investments predominantly in equity and equityrelated instruments of pharma, healthcare and allied companies.

  • Minimum Application Amount - Rs. 1,000/- per application and in multiples of Re. 1/- thereafter

  • Plan/ Options available - Regular plan & Direct plan having Growth Option and Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of Income Distribution cum capital withdrawal option and Reinvestment of Income Distribution cum capital withdrawal option).

  • Fund Managers - Mr. Aditya Khemani

  • Benchmark - BSE Healthcare TRI
Download - KIM
Download - SID

(Mutual Fund investments are subject to market risks, read all scheme related documents carefully.)

Realted Blogs
Tax-Efficient Investment Strategies for Indian Investors in 2026
20 Aug,  2026 #Mutual Funds
Top Performing Debt Funds in India 2026
20 Aug,  2026 #Mutual Funds
info
Wealth Management Services
Sit back and relax, while we take care of all your financial needs.
Lets Start a Conversation
Have you checked our latest Monthly Digest?
Explore More
Mutual Fund Research
View More
Did You Know?
Eastern Financiers, one of the first investment and financial consultant in Eastern India have grown to become one of the largest investment consultants in the country.
Learn More About Us